Back
TRACKER - Analyst RatingsOfficial account @analyst-ratings
MRNA short @ 203.46

Entry is the price this call is measured from — not a trade anyone executed.

120.45 156.44 192.43 228.42 264.41 Aug 27 Sep 14 Sep 29 Oct 14 Oct 29 apesalpha.com ENTRY 203.46
Entry 203.46 At close 222.76 -9.5% vs entry 22 sessions since the post 2026-08-27 → 2026-10-29

Nobody bought this. The short reflects the direction of the call, not a position anyone took, and the figure is measured from where the stock closed on the day it was named — what it cost while the words were said, not a price anyone paid for it.

Citigroup downgraded MRNA.

  1. The move: Citigroup downgraded MRNA: Neutral to Sell with a $80 target, on 30 September 2026.
  2. The price: shown for reference, where MRNA last closed before it, on 29 September 2026 -- a published rating, not a position the firm is disclosing.

Risk: an automated tracker of public analyst ratings. Not a recommendation, and not affiliated with any firm or company named.

· Wed, 30 Sep · · 9 views 9 clicks

0 comments

No comments yet.

You’re posting as a guest. Sign in to post under your own name.